CYBIN Inc $CYBN CEO Interview | Benzinga

Today Cybin announced that you are commencing dosing of your CYB004 psychedelic-based molecule in humans. Can you tell us about CYB004? Can you walk us through any data you have shared so far on CYB004? What is the importance of this advancement at this stage in development? What differentiates CYB004 from other psychedelic-based molecules currently in development? Why does Cybin believe that CYB004 has promise in treating anxiety disorders? Featured Guest: @heluspharma $CYBN, CEO Doug Drysdale PRO TOOLS: 📈pro.benzinga.com 👉What Is Benzinga Pro? 👉https://www.youtube.com/watch?v=HfE5b6NxUis ✅Free 2 week trial, no credit card required✅ 🙌Use coupon code YOUTUBE20 to get 20% off🙌 WEBSITE & SOCIALS: 💻 Website: https://www.benzinga.com 👍Benzinga on Instagram & Facebook @ Benzinga 🛎Benzinga on TikTok & Twitter @ Benzinga 📺Benzinga on Discord: https://discord.gg/pbbdfSKGym MERCH: 👕https://swag.benzinga.com/ FREE RESOURCES: 📮Cannabis Insider Newsletter: https://share.hsforms.com/1SD_FsDd8TnS-RYQYnORPFw1npzh 📑Market In 5 Minutes Newsletter: https://share.hsforms.com/1SoPsxeyZRGaNV52R_Z7CKQ1npzh BENZINGA’s CORE BUSINESSES: ✅Financial news articles: http://benzinga.com ✅Real-time news headlines: http://pro.benzinga.com ✅Financial, Market, and Alternative data APIs: http://cloud.benzinga.com ✅The Benzinga Global Fintech Awards: http://benzingafintechawards.com Disclaimer: All of the information, material, and/or content contained in this program is for informational purposes only. Investing in stocks, options, and futures is risky and not suitable for all investors. Please consult your own independent financial adviser before making any investment decisions. #Benzinga #BenzingaPro #Stocks